Charge Variant and Aggregation Analysis of Innovator and Biosimilars of Rituximab

Applications | 2019 | Agilent TechnologiesInstrumentation
Consumables, HPLC, LC columns
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Charge Heterogeneity Analysis of Rituximab Innovator and Biosimilar mAbs
Seamless Method Transfer from an Agilent 1260 Infinity Bio-inert LC to an Agilent 1260 Infinity II Bio-inert LC
Analysis of Charge Heterogeneity in Rituximab Innovator and Biosimilar Monoclonal Antibodies Using Salt-Gradient Cation Exchange Chromatography
Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC